MC
STTK icon

Middleton & Co’s Shattuck Labs STTK Stock Holding History

Middleton & Co’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+30,000
New +$187K 0.02% 164

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Middleton & Co's STTK Position: Q2 2026 in Review

Middleton & Co opened a new position in Shattuck Labs (STTK) in Q2 2026: 30,000 shares worth $208K. The stake represents 0.02% of the portfolio and ranks #164 among its holdings.

100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Middleton & Co held 30,000 shares of Shattuck Labs worth $208K as of Q2 2026.
  • Shattuck Labs was a new Middleton & Co position in Q2 2026.
  • Shattuck Labs made up 0.02% of Middleton & Co's portfolio in Q2 2026, its #164 holding.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Middleton & Co's 13F filing for Q2 2026, filed 10 Aug 2026.